Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

A Maturity Level Model (MLM) for the self-assessment of genomic medicine practices in healthcare systems

Title: A Maturity Level Model (MLM) for the self-assessment of genomic medicine practices in healthcare systems
Authors: Cardoso, maria Luis; Lopes, Fatima; Costa, Alexandra; Santos, Osvaldo; Konopko, Melissa; Merchant, Arshiya; Thorogood, Adrian; Saunders, Gary; Custers, Ilse; Bulcke, Marc Van Den; Schmitt, Tugce; Bogicevic, Ivana; Cividanes, Lene; Spalding, Dylan; Smith, Maeve; Bale, Mark; Pitini, Erica; Villari, Paolo; Baccolini, Valentina; Balciuniene, Anzelika; Ambrozaityte, Laima; Doménech, Elena; Martin-Sanchez, Fernando; Sobrón, Francisco; Saiz, Maria Luisa; Carracedo, Angel; Wedell, Anna; Thomsen, Anne Cambon; Veimer, Annika; Lundgren, Bettina; Solary, Eric; Birney, Ewan; Martins, Henrique; Klovins, Janis; Saarela, Janna; North, Kathryn; Caulfield, Mark; Piha, Tapani; Scollen, Serena; Vicente, Astrid
Publisher Information: Zenodo
Publication Year: 2023
Collection: Zenodo
Subject Terms: Beyond 1M Genomes; Genome of Europe; genomics; 1+MG
Description: Genomic medicine implementation in healthcare systems can bring us one step closer to making personalised medicine a reality, with major socioeconomic benefits. Citizens and patients can widely benefit from genomic data analysis for accurate and timely diagnosis, effective treatments with less adverse events, and accurate profiling for disease prevention. Implementation of genomics in healthcare is complex and requires adjustments in the governance, structure and organization of health services, as well as dedicated investments. Implementation is also dependent on the country context. In the context of the 1+Million Genomes (1+MG) initiative, we developed a Maturity Level Model (MLM) for health systems to self-evaluate the maturity of their genomic medicine practices, and define a path to optimization. MLM is a tool for healthcare systems to self-evaluate the level of maturity of their genomic medicine practices according to a common matrix, and to define a path to optimization. A MLM pilot in eight European countries provided important information regarding common strengths, weaknesses and asymmetries across Europe.
Document Type: text
Language: unknown
Relation: https://zenodo.org/communities/b1mg/; https://zenodo.org/communities/eu/; https://zenodo.org/records/8135894; oai:zenodo.org:8135894; https://doi.org/10.5281/zenodo.8135894
DOI: 10.5281/zenodo.8135894
Availability: https://doi.org/10.5281/zenodo.8135894; https://zenodo.org/records/8135894
Rights: Creative Commons Attribution 4.0 International ; cc-by-4.0 ; https://creativecommons.org/licenses/by/4.0/legalcode
Accession Number: edsbas.20C539DD
Database: BASE